ONE OF THE BIOCHEMICAL MARKERS for human and animal tumours is the accumulation of certain ether lipids which may be measured collectively as O-alkylglycerols in the neutral lipids fraction (Snyder & Wood, 1969) . These lipids are increase(I in a wide variety of neoplastic cells (Friedberg & Halpert, 1978) and malignant tissues including human HCC Lin et al., 1978) . Tumour markers may be useful in the study of possibly premalignant conditions. If they are known to be early markers, their appearance may confirm the characterization of some conditions as cancerous. Whilst little is known about the ether lipid marker, it was reported to appear in rat thymus long before leukaemia developed in radiation-induced leukaemogenesis (Brown et al., 1975) . This report concerns a search for the marker in liver tissue from Chinese in Hong Kong who had both hepatitis B infection and cirrhosis. The reason for studying these cases was the close statistical association between hepatitis B infection, macronodular cirrhosis and HCC in the local population. HBsAg was present in 3300 of liver biopsy specimens from cases of HCC without cirrhosis, and in 790 of those with both cirrhosis and HCC (Wu, 1978) . The possible connection between hepatitis infection (often with resulting cirrhosis) and HCC has been noted among groups in North America, Europe and Africa (Peters et al., 1977; Bassendine et al., 1979; Blumberg et al., 1975) . Asian populations similarly affected include the Japanese (Shikata et al., 1977) , Indians (Nayak et al., 1977) and Chinese in Taiwan (Tong et al., 1971) . The search for the marker was therefore carried out on liver tissue with both cirrhosis and HBsAg. These tissues were grouped according to the presence or absence of HCC in the organ, on the supposition that 1CC might affect the metabolism of residual liver tissue. Great care was exercised in the selection of residual liver specimens. Systematic naked-eye and histological examinations of the tissues were carried out in every case, and only those specimens in which no tumour cells wvere found were included in this study.
Our findings showed a difference in the frequency with which the marker appeared in liver tissue from organs with and without HCC.
Tissue specimens. Tissue histology.-Routine haematoxylinand-eosin-stained sections of the liver specimens were examined. About 10-20 blocks from each case wAere studied. The stage and activity of cirrhosis were noted. Data on liver-cell dysplasia were obtained using the criteria outlined by Anthony et al. (1973) . HCC specimens showed either no clear cells, or a focal or diffuse pattern of clear cells (Lai et al. (in press ).
Assays of HBsAg.-The presence or absence of hepatitis B antigenaemia was noted from the clinical records, and where this had not been analysed blood was obtained post mor-tem for radioimmunoassay of HBsAg.
HBsAg in liver was assessed by Gomori's aldehyde fuchsin stain and by immunofluorescence . In a previous study, we found that these histological methods were sensitive indicators of HBsAg status; HBsAg staining was occasionally detected in liver cells from serologically negative subjects (Ho et al. (in press) ). Blood and histological tests for HBsAg showed complete concordance in all the specimens examined in this study.
Biochemical methods. The procedures for the colorimetric estimation of O-alkylglycerols in the neutral lipids fraction, and the gas-chromatographic analysis of O-alkylglycerols have been given before (Lin et al., 1977 .
The histological basis for studying HB antigenaemia and liver cirrhosis was the frequency with which dysplasia was seen in the tissues. Liver-cell dysplasia has been characterized as a premalignant change associated with liver-cell cancer (Anthony et al., 1973) . This view has been supported by the finding of localized ci-foetoprotein production in dysplastic liver cells from patients with chronic liver disease (Okita et al., 1977) . Fig. 1 shows the close association between liver-cell dysplasia and HBsAg+ cirrhotic liver. Dysplasia was present in 1/24 noncancerous liver specimens without HBsAg or cirrhosis (Group I); in 13/16 HBsAg+ cirrhotic specimens within Group II, noncancerous liver; and in 16/19 specimens of HBsAg+ cirrhotic specimens within Group III, liver with HCC. The percentage values in the 3 groups were respectively 4-2, 812 and 84-2. The differences between the first value and either of the other two were significant at the 0 0005 level (X2 test). These results were similar to the findings of Anthony et al. (1973) also shown in Fig. 1 . The mean value for all results in Group III was 0 97 + 1-2 ,.g/g, which was significantly higher than the mean of Groups I and II (0 45 + 0 38) and lower than those in 1CC (8.8 + 9.9 ,ug/g). The probabilities associated with these two differences were both at the 0-01 level (variance-ratio test). The observed changes could not be attributed to differences in the total lipid content of the various tissues, which were about 30 mg/g in all 4 groups. Nor could they be reasonably ascribed to the presence of tumour cells missed in the course of histological examination. Several specimens within Group III had neutral 0-alkylglycerolipid levels representing 9-15% of the levels found in their corresponding tumours. The chances that microscopic examination could have overlooked 1 cancer cell among 10 hepatocytes, or even 1 in 7, were remote.
The view that some specimens in Group III resembled HCC in respect of these ether lipids was supported by analysis of ether-linked side chains. This type of analysis gave information on the composition of the ether lipids in question, t Difference from the second value in the column, P < 0-02; from the third value, P < 0-025.
and was therefore independent of the measurement of ether lipid level. It was found in a previous study that the etherlinked side chains in HCC had more C16 and fewer C1s groups than non-cancerous liver . We therefore analysed most of the specimens in the present series; the results are presented in the Table. It was found, first of all, that slightly higher C16 :C18 ratios were obtained in non-cancerous liver with HBsAg and cirrhosis, than in the same tissue with neither of these factors. For this reason, the further comparison of C16:C18 ratios in Group III specimens could only be made with HBsAg+, cirrhotic specimens. Residual liver specimens without the marker (i.e. with neutral O-alkylglycerolipids levels below 1 2 pg/g) had ratios not different from those in non-cancerous HBsAg+, cirrhotic liver. In contrast, specimens with the marker had significantly higher C16:C18 ratios, which were in fact similar to those found in HCC. These results showed that there was a slight increase in C16 :C18 ratios as the result of the co-existing conditions of hepatitis and cirrhosis, and a much larger increase (seen in HCC) associated with malignancy. Among the specimens within Group III with hepatitis and cirrhosis, specimens which had normal levels of the ether lipids showed only a slight change; those with high ether lipids levels showed a further increase in the C16 :C18 ratio. The latter may be attributable to malignancy.
Since the tumour marker is defined by an increase in the amount of neutral 0-alkylglycerolipids, and not a change in the composition of the ether-linked side chains, the conclusions must be that the marker was absent from non-cancerous, HBsAg+, cirrhotic liver, and present in some specimens of HIBsAg+ liver from cases of 11CC. The positive finding in this study was that the appearance of the ether lipid marker in liver depended on the presence of HCC in the same organ. This could be explained in two ways: either the ether lipids were secreted by the tumour and taken up by the adjacent residual tissues, or they were synthesized within hepatocytes morphologically unlike cancer cells.
